Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Dantzer

Showing results (191-200 of 218) with videos related to

Pageof 22
Sort By:
Brain, Behavior, and Immunity|August 1, 2021
Neuroimmune mechanisms of cognitive impairment in a mouse model of Gulf War illnessJoshua D Bryant, Maheedhar Kodali, Bing Shuai, et al.
Brain, Behavior, and Immunity|January 9, 2022
Peripheral and central kynurenine pathway abnormalities in major depressionElisabeth R Paul, Lilly Schwieler, Sophie Erhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2010
Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERKNiels Eijkelkamp, Huijing Wang, Anibal Garza-Carbajal, et al.
Molecular Medicine (Cambridge, Mass.)|February 15, 2012
G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signalingNiels Eijkelkamp, Cobi J Heijnen, Anibal Garza Carbajal, et al.
Psychoneuroendocrinology|August 2, 2015
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorderJonathan Savitz, Robert Dantzer, Timothy B Meier, et al.
Cancer|May 27, 2003
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptomsCharles S Cleeland, Gary J Bennett, Robert Dantzer, et al.
Brain, Behavior, and Immunity|March 16, 2026
Obesity, low-grade inflammation, and inflammatory response to immune challenge modulate willingness to expend effort for rewardIris Ka-Yi Chat, Lina S Hansson, Mats Lekander, et al.
Frontiers in Immunology|August 2, 2021
Inhibition of Tryptophan Catabolism Is Associated With Neuroprotection During <i>Zika</i> Virus InfectionFernanda Martins Marim, Danielle Cunha Teixeira, Celso Martins Queiroz-Junior, et al.
Psychopharmacology|January 6, 2019
The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathwayAngela Maria Casaril, Micaela Domingues, Suely Ribeiro Bampi, et al.
Brain, Behavior, and Immunity|March 29, 2021
Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathwayAuriel A Willette, Colleen Pappas, Nathan Hoth, et al.
Pageof 22

Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Brain, Behavior, and Immunity|August 1, 2021
Neuroimmune mechanisms of cognitive impairment in a mouse model of Gulf War illnessJoshua D Bryant, Maheedhar Kodali, Bing Shuai, et al.
Brain, Behavior, and Immunity|January 9, 2022
Peripheral and central kynurenine pathway abnormalities in major depressionElisabeth R Paul, Lilly Schwieler, Sophie Erhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 24, 2010
Low nociceptor GRK2 prolongs prostaglandin E2 hyperalgesia via biased cAMP signaling to Epac/Rap1, protein kinase Cepsilon, and MEK/ERKNiels Eijkelkamp, Huijing Wang, Anibal Garza-Carbajal, et al.
Molecular Medicine (Cambridge, Mass.)|February 15, 2012
G protein-coupled receptor kinase 6 acts as a critical regulator of cytokine-induced hyperalgesia by promoting phosphatidylinositol 3-kinase and inhibiting p38 signalingNiels Eijkelkamp, Cobi J Heijnen, Anibal Garza Carbajal, et al.
Psychoneuroendocrinology|August 2, 2015
Activation of the kynurenine pathway is associated with striatal volume in major depressive disorderJonathan Savitz, Robert Dantzer, Timothy B Meier, et al.
Cancer|May 27, 2003
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptomsCharles S Cleeland, Gary J Bennett, Robert Dantzer, et al.
Brain, Behavior, and Immunity|March 16, 2026
Obesity, low-grade inflammation, and inflammatory response to immune challenge modulate willingness to expend effort for rewardIris Ka-Yi Chat, Lina S Hansson, Mats Lekander, et al.
Frontiers in Immunology|August 2, 2021
Inhibition of Tryptophan Catabolism Is Associated With Neuroprotection During <i>Zika</i> Virus InfectionFernanda Martins Marim, Danielle Cunha Teixeira, Celso Martins Queiroz-Junior, et al.
Psychopharmacology|January 6, 2019
The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathwayAngela Maria Casaril, Micaela Domingues, Suely Ribeiro Bampi, et al.
Brain, Behavior, and Immunity|March 29, 2021
Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathwayAuriel A Willette, Colleen Pappas, Nathan Hoth, et al.
Pageof 22